DPP4 and peripheral arterial disease: The large retrospective Taiwanese cohort study by Lin et al. focused on the effect of GLP-1RA on a composite outcome comprising incident peripheral artery disease, critical limb ischemia, lower limb angioplasty or by-pass, and amputation compared to dipeptidyl peptidase-4 inhibitors (DPP-4i) [23].